Greenoaks Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carvana
CVNA
|
+$114M |
| 2 |
SOND
Sonder
SOND
|
+$114M |
| 3 |
Snowflake
SNOW
|
+$77M |
| 4 |
Samsara
IOT
|
+$70.8M |
| 5 |
Upwork
UPWK
|
+$58.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$1.42B |
| 2 |
Clover Health Investments
CLOV
|
+$92.4M |
| 3 |
Peloton Interactive
PTON
|
+$16M |
| 4 |
GoodRx Holdings
GDRX
|
+$10.8M |
| 5 |
SMAR
Smartsheet Inc.
SMAR
|
+$5.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 70.71% |
| 2 | Technology | 20.65% |
| 3 | Communication Services | 8.64% |
| 4 | Healthcare | 0% |
| 5 | Industrials | 0% |
Similar funds
Greenoaks Capital Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Greenoaks Capital Partners held 18 positions worth $1.61B, down 60% from $4.05B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Greenoaks Capital Partners withdrew a net $1.04B in Q1 2022, closing 4 positions and reducing 4 holdings. Its most notable exit was Clover Health Investments, an estimated $92.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 71% of assets, down from 89% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Greenoaks Capital Partners opened a new position in Carvana worth $93.2M.
- Greenoaks Capital Partners's largest Q1 2022 buy was Carvana: 3,906,420 shares worth $93.2M.
- Greenoaks Capital Partners added most to Snowflake in Q1 2022, an estimated $77M increase.
- Greenoaks Capital Partners's biggest Q1 2022 reduction was Coupang, cutting an estimated $1.42B.
- Greenoaks Capital Partners fully exited Clover Health Investments in Q1 2022, selling an estimated $92.4M.
- Greenoaks Capital Partners's ten largest holdings make up 99% of its $1.61B portfolio in Q1 2022.
- Greenoaks Capital Partners opened 3 new positions and closed 4 in Q1 2022.
- Greenoaks Capital Partners's portfolio value fell 60% quarter-over-quarter to $1.61B.
Based on Greenoaks Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.